Closing Bell: Knight Therapeutics Inc up on Wednesday (GUD)
Today in trading, Knight Therapeutics Inc shares opened at $5.67 and closed at $5.64. prices ranged from a low of $5.60 to a high of $5.68.
Shares boosted 1.08 percent from the previous day's close of $5.58.
Today across North America, the TSX Composite closed 1.40% at 22350.23, the S&P 500 closed 0.07% at 5576.98, the Dow Jones Industrial Average closed -0.13% at 39291.97 and the Nasdaq Composite closed 0.14% at 18429.29.
Knight Therapeutics Inc has listed on the Toronto Stock Exchange (TSX) under the ticker GUD.
Trading volume was 57,931 on 244 total trades. On average, Knight Therapeutics Inc has traded 47,668 shares in the last five days and 67,344 year-to-date.
Trading across the entire TSX saw 3,274 price advancers against 1,962 declines and 102 unchanged.
During the prior 52 weeks, GUD.TO has traded as high as $6.22 (May 15,2024) and low as $4.35 (October 23,2023). Moreover, the shares have advanced 14.40 percent in the last 12 months, while they have advanced 8.67% since the start of 2024.
Following today's trading, Knight Therapeutics Inc has a market capitalization of $565.68 million on a float of 101,376 shares outstanding. Its annual EPS is $-0.16.
Knight Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Montreal, CAN.
Currently, Knight Therapeutics Inc's consensus rating is "Moderate Buy" based on 4 analysts according to Zacks. Currently, there are 3 buy ratings and 1 hold ratings for the stock.
AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..
